FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024104162> ?p ?o ?g. }

• W2024104162 endingPage "51" @default.
• W2024104162 startingPage "45" @default.
• W2024104162 abstract "We have used somatostatin (SRIF) receptor subtype-selective ligands to determine some of the operational characteristics of somatostatin receptors in Neuro2A mouse neuroblastoma cells. The potent SRIF1-receptor selective ligand, BIM-23027, was able to displace completely the specific binding of radioiodinated somatostatin, [125I]-Tyr11-SRIF-14, with a pIC50 of 10.3, suggesting that Neuro2A cells contain predominantly receptors of the SRIF1 receptor group. The rank order of affinities for several somatostatin analogues tested in competition studies, together with the high affinity of BIM-23027, indicate that the majority of receptors in Neuro2A cells are of the sst2 subtype. The stable radioligand, [125I]-BIM-23027, bound with high affinity (Kd=13 pm, Bmax=0.2 pmol mg−1 protein) to Neuro2A cell membranes, but its binding was only partially reversible at room temperature and below. Thus at 4°C, only 36% of the bound ligand dissociated within 2 h. In contrast, 60% of the ligand dissociated at 15°C and 89% of the ligand dissociated at 37°C. Equilibrium binding of [125I]-BIM-23027 was partially (25%) inhibited by 10 μm GTP, and by 120 mm NaCl (42% inhibition) but this inhibition was increased to 75% when sodium chloride and GTP were added together. This effect of GTP and sodium chloride was also seen in dissociation experiments. After incubation to equilibrium with [125I]-BIM-23027, dissociation was initiated with excess unlabelled ligand in the presence of GTP (10 μm) and sodium chloride (120 mm). Under these conditions 67% of the ligand dissociated at 4°C, 81% at 15°C and 93% at 37°C. Binding was totally inhibited by pretreatment of cells with pertussis toxin. Functionally, BIM-23027 inhibited forskolin-stimulated cyclic AMP accumulation in a concentration-dependent manner with an IC50 of 1.0 nm and a maximal inhibition of 37%. This effect was abolished by pretreatment of the cells with pertussis toxin. However, unlike in studies reported with the recombinant sst2 receptor, no rise in intracellular calcium concentration was observed with SRIF-14. We conclude that Neuro2A cells provide a stable neuronal cell line for the study of functionally coupled endogenous somatostatin receptors of the sst2 type. In addition, we have found that activation of the receptor is associated with ligand-receptor internalisation. British Journal of Pharmacology (1997) 120, 45–51; doi:10.1038/sj.bjp.0700858" @default.
• W2024104162 created "2016-06-24" @default.
• W2024104162 creator A5041298768 @default.
• W2024104162 creator A5070427239 @default.
• W2024104162 creator A5070875674 @default.
• W2024104162 date "1997-01-01" @default.
• W2024104162 modified "2023-09-26" @default.
• W2024104162 title "Somatostatin receptors in Neuro2A neuroblastoma cells: operational characteristics" @default.
• W2024104162 cites W1522062003 @default.
• W2024104162 cites W1526437569 @default.
• W2024104162 cites W1967368337 @default.
• W2024104162 cites W1968613009 @default.
• W2024104162 cites W1972074984 @default.
• W2024104162 cites W1983547991 @default.
• W2024104162 cites W1985189889 @default.
• W2024104162 cites W1990148629 @default.
• W2024104162 cites W1994090158 @default.
• W2024104162 cites W1997021821 @default.
• W2024104162 cites W2000052819 @default.
• W2024104162 cites W2005887351 @default.
• W2024104162 cites W2012905804 @default.
• W2024104162 cites W2031266705 @default.
• W2024104162 cites W2032515982 @default.
• W2024104162 cites W2032664457 @default.
• W2024104162 cites W2042071333 @default.
• W2024104162 cites W2043212483 @default.
• W2024104162 cites W2043813981 @default.
• W2024104162 cites W2054386830 @default.
• W2024104162 cites W2057159931 @default.
• W2024104162 cites W2069108719 @default.
• W2024104162 cites W2092970474 @default.
• W2024104162 cites W2095312317 @default.
• W2024104162 cites W2131544215 @default.
• W2024104162 cites W2131690895 @default.
• W2024104162 cites W4293247451 @default.
• W2024104162 doi "https://doi.org/10.1038/sj.bjp.0700858" @default.
• W2024104162 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1564336" @default.
• W2024104162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9117097" @default.
• W2024104162 hasPublicationYear "1997" @default.
• W2024104162 type Work @default.
• W2024104162 sameAs 2024104162 @default.
• W2024104162 citedByCount "18" @default.
• W2024104162 countsByYear W20241041622012 @default.
• W2024104162 countsByYear W20241041622013 @default.
• W2024104162 countsByYear W20241041622014 @default.
• W2024104162 countsByYear W20241041622015 @default.
• W2024104162 countsByYear W20241041622017 @default.
• W2024104162 countsByYear W20241041622023 @default.
• W2024104162 crossrefType "journal-article" @default.
• W2024104162 hasAuthorship W2024104162A5041298768 @default.
• W2024104162 hasAuthorship W2024104162A5070427239 @default.
• W2024104162 hasAuthorship W2024104162A5070875674 @default.
• W2024104162 hasBestOaLocation W20241041621 @default.
• W2024104162 hasConcept C116569031 @default.
• W2024104162 hasConcept C118716 @default.
• W2024104162 hasConcept C12554922 @default.
• W2024104162 hasConcept C126322002 @default.
• W2024104162 hasConcept C134018914 @default.
• W2024104162 hasConcept C170493617 @default.
• W2024104162 hasConcept C178790620 @default.
• W2024104162 hasConcept C181199279 @default.
• W2024104162 hasConcept C185592680 @default.
• W2024104162 hasConcept C2776297358 @default.
• W2024104162 hasConcept C537181965 @default.
• W2024104162 hasConcept C55493867 @default.
• W2024104162 hasConcept C67847695 @default.
• W2024104162 hasConcept C71240020 @default.
• W2024104162 hasConcept C71924100 @default.
• W2024104162 hasConcept C80115893 @default.
• W2024104162 hasConcept C86803240 @default.
• W2024104162 hasConceptScore W2024104162C116569031 @default.
• W2024104162 hasConceptScore W2024104162C118716 @default.
• W2024104162 hasConceptScore W2024104162C12554922 @default.
• W2024104162 hasConceptScore W2024104162C126322002 @default.
• W2024104162 hasConceptScore W2024104162C134018914 @default.
• W2024104162 hasConceptScore W2024104162C170493617 @default.
• W2024104162 hasConceptScore W2024104162C178790620 @default.
• W2024104162 hasConceptScore W2024104162C181199279 @default.
• W2024104162 hasConceptScore W2024104162C185592680 @default.
• W2024104162 hasConceptScore W2024104162C2776297358 @default.
• W2024104162 hasConceptScore W2024104162C537181965 @default.
• W2024104162 hasConceptScore W2024104162C55493867 @default.
• W2024104162 hasConceptScore W2024104162C67847695 @default.
• W2024104162 hasConceptScore W2024104162C71240020 @default.
• W2024104162 hasConceptScore W2024104162C71924100 @default.
• W2024104162 hasConceptScore W2024104162C80115893 @default.
• W2024104162 hasConceptScore W2024104162C86803240 @default.
• W2024104162 hasIssue "1" @default.
• W2024104162 hasLocation W20241041621 @default.
• W2024104162 hasLocation W20241041622 @default.
• W2024104162 hasLocation W20241041623 @default.
• W2024104162 hasLocation W20241041624 @default.
• W2024104162 hasOpenAccess W2024104162 @default.
• W2024104162 hasPrimaryLocation W20241041621 @default.
• W2024104162 hasRelatedWork W1937350043 @default.
• W2024104162 hasRelatedWork W1968829248 @default.
• W2024104162 hasRelatedWork W1974085413 @default.
• W2024104162 hasRelatedWork W2006132562 @default.

• next